查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1756482

患者血液管理市场（按产品、组件、最终用户、国家和地区）－2024 年至 2032 年产业分析、市场规模、市场份额及预测

Patient Blood Management Market, By Product, By Component, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 365 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年病患血液管理市场规模价值 154.7898 亿美元，2024 年至 2032 年的复合年增长率为 7.98%。

病患血液管理市场-市场动态

贫血和慢性病盛行率上升

贫血以及心血管疾病、癌症和肾臟病等慢性疾病的日益流行，是推动患者血液管理 (PBM) 市场成长的主要动力。这些疾病通常会导致大量失血或红血球生成减少，因此需要更有效的血液管理策略。随着全球人口老化和这些疾病发病率的上升，医疗保健提供者正在转向 PBM 来优化血液使用，减少输血需求，并改善患者预后。 PBM 策略透过客製化疗法和介入措施帮助管理贫血，降低输血相关风险并促进復原。因此，日益加重的慢性疾病负担正在推动对 PBM 解决方案的需求，这些解决方案专注于最大限度地减少失血，改善红血球生成，并提供传统输血的替代方案。这一趋势对市场扩张产生了重大影响。

病患血液管理市场-关键见解

根据我们的研究分析师，全球患者血液管理市场预计在 2024 年至 2032 年期间的复合年增长率约为 7.98%。

按 2024 年的产品细分，仪器类别占据了市场主导地位。

根据最终用户细分，医院在 2024 年创造了最多的收入。

按地区划分，2024年北美是收入最高的地区。

病患血液管理市场-細項分析：

全球患者血液管理市场分为三类：产品、组件、最终用户和地区。

患者血液管理 (PBM) 市场分为四个主要产品类别：仪器、配件、试剂和套件以及软体。其中，仪器预计将占据市场主导地位。此部分包括用于监测和管理血液相关疾病的血液采集系统、血液处理设备和诊断仪器等设备。仪器的主导地位归因于它们在实现准确血液分析、减少失血和加强临床环境中的输血实践方面发挥关键作用。由于 PBM 强调最大限度地减少失血和优化血液使用，因此仪器对于实现这些目标至关重要。此外，医疗技术的进步和节血手术技术的日益普及推动了对创新高性能仪器的需求。精准血液管理在手术和重症监护中的重要性，加上医疗保健投资的增加，使仪器成为 PBM 市场中的领先产品类别。

依最终用户划分，市场分为血库、医院、诊断诊所和病理实验室。其中，医院将占据主导地位。医院是PBM实践应用最广泛的主要医疗机构，尤其是在外科手术、创伤护理和重症病人管理方面。由于输血量、手术量和病人入院量庞大，医院需要全面的PBM系统来管理失血、优化血液使用并降低输血相关风险。复杂手术数量的增加、慢性病发病率的上升以及对改善患者预后的重视，推动了PBM在医院的日益普及。此外，医院越来越多地采用先进的血液管理技术，有助于PBM实践的扩展。虽然血库和诊断诊所也在PBM中发挥重要作用，但由于医院直接参与病患照护和治疗，它仍然是主要的最终使用者。

患者血液管理市场-地理洞察

从地理分布来看，患者血液管理市场分布于北美、亚太地区、拉丁美洲、欧洲、中东和非洲。这些地区根据业务来源国进一步划分。

北美是患者血液管理 (PBM) 市场的主导地区，这得益于其先进的医疗基础设施以及医院和医疗机构日益普及的 PBM 实践。美国引领这一市场，其医疗保健系统日益重视透过 PBM 解决方案减少输血相关併发症并优化患者治疗效果。 FDA 等机构的监管支持，以及人们对 PBM 益处日益增长的认识，进一步推动了其应用。此外，主要市场参与者的存在以及血液管理仪器的持续技术进步，也巩固了北美市场的领先地位。该地区强劲的医疗支出和需要复杂医疗治疗的老龄化人口进一步推动了对 PBM 解决方案的需求。

欧洲是PBM市场的另一个关键区域，其显着成长得益于强大的医疗保健体系、人口老化以及对减少失血和输血的日益重视。德国、英国和法国等国家引领欧洲市场，这些国家的医疗保健机构越来越多地采用PBM实践来提高病患安全性并降低医疗成本。欧盟的医疗保健政策支持PBM策略的实施，尤其是在医院和外科中心。此外，医疗技术的进步，例如节血手术器械和诊断工具，在推动市场成长方面发挥关键作用。欧洲在医疗保健和患者护理方面的进步方法确保了该地区对PBM解决方案的持续需求。

病患血液管理市场-竞争格局：

患者血液管理 (PBM) 市场的竞争态势由老牌企业和新兴创新者共同塑造。 Haemonetics Corporation、Fresenius SE & Co. KGaA、Terumo Corporation 和 Immucor, Inc. 等大公司引领市场，提供一系列先进的 PBM 解决方案，这些解决方案优先考虑安全性、效率和对监管标准的合规性。这些公司非常注重研发，以改善血液管理系统和增强输血规程。新参与者也带着创新技术进入市场，例如先进的诊断工具和节血手术器械。这些公司之间的竞争促进了产品的持续改进，并确保了高品质 PBM 解决方案的稳定供应。例如，F. Hoffmann-La Roche Ltd. 和 Grifols, SA 一直在积极扩展其产品组合，而 B. Braun Melsungen AG 和 Bio-Rad Laboratories, Inc. 则继续透过策略性收购和合作巩固其地位。

最新动态：

2023年，Grifols从BPL Plasma Inc.收购了美国25家血浆捐赠中心，使其年产能提升约100万公升。这项策略性倡议巩固了Grifols在血浆采集领域的全球领导地位，并支持了日益增长的血浆衍生疗法需求。此次收购符合Grifols致力于增加患者获得救命治疗的机会的承诺。

2024年10月，Terumo血液与细胞技术公司与美国血液中心合作，在美国推出了Reveos™自动化血液处理系统。此系统可自动将全血分离成血小板、血浆和红血球等成分，从而简化流程并提高效率。 Reveos旨在提升血液中心的运作效率，满足日益增长的血液製品需求。

2022年8月，雅培实验室推出了一款全新的血液检测平台，旨在提高患者血液管理中诊断的准确性和速度。此先进平台支援医疗服务提供者及时做出明智的决策，优化患者预后，并减少不必要的输血需求。雅培的创新彰显了其致力于推动PBM实践的承诺。

目录

第 1 章：病患血液管理市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 病患血液管理市场产品片段
    • 病患血液管理市场片段（按组件）
    • 患者血液管理市场片段（按最终用户）
    • 患者血液管理市场（按国家/地区）
    • 病患血液管理市场（按地区）
  • 竞争洞察

第三章：病患血液管理关键市场趋势

  • 患者血液管理市场驱动因素
    • 市场驱动因素的影响分析
  • 患者血液管理市场限制
    • 市场限制的影响分析
  • 病患血液管理市场机会
  • 患者血液管理市场未来趋势

第四章：病患血液管理产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：病患血液管理市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：病患血液管理市场格局

  • 2023年病患血液管理市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：患者血液管理市场－依产品

  • 概述
    • 按产品细分的市占率分析
    • 仪器
      • 血液处理设备
      • 离心机
      • 血球处理器
      • 输血设备
      • 血液分离机
      • 血浆和血浆成分分离器
      • 细胞回收系统
      • 其他输血设备
      • 血液培养筛检设备
      • 自动化血液培养系统
      • 配套实验室设备
      • 诊断和测试仪器
      • PCR仪器
      • 血液学分析仪
      • NGS平台
      • 血型分析仪
      • 血液储存设备
      • 医用冰箱
      • 医用冷冻柜
    • 配件
      • 注射器和针头
      • 小瓶和试管
      • 血袋
      • 其他配件
    • 试剂和试剂盒
      • 血培养基
      • 血型鑑定试剂
      • 玻片染色试剂
      • 检测试剂盒
      • 其他试剂
    • 软体
      • 血库管理软体
      • 输血管理软体
      • 其他软体

第 8 章：病患血液管理市场 - 按组件

  • 概述
    • 按组件分類的细分市场占有率分析
    • 全血和红血球
    • 电浆

第九章：患者血液管理市场－依最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 血库
    • 医院
    • 诊断诊所和病理实验室

第 10 章：病患血液管理市场 - 按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美患者血液管理主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按产品）
    • 北美市场规模及预测（按组件）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲患者血液管理主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按产品）
    • 欧洲市场规模及预测（按组成部分）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区患者血液管理主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（按产品）
    • 亚太市场规模及预测（按组成部分）
    • 亚太市场规模及预测（依最终用户）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲患者血液管理主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按产品）
    • 拉丁美洲市场规模及预测（按组成部分）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲患者血液管理主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按产品）
    • 中东和非洲市场规模及预测（按组成部分）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：关键供应商分析-病患血液管理产业

  • 竞争仪錶板
  • 公司简介
    • Haemonetics Corporation
    • Fresenius Se & Co. KGaA
    • Terumo Corporation
    • Immucor, Inc.
    • B. Braun Melsungen AG
    • Macopharma
    • Biomerieux SA
    • Kaneka Corporation
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories
    • Grifols, SA
    • F. Hoffmann-La Roche Ltd.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5344

REPORT HIGHLIGHT

Patient Blood Management Market size was valued at USD 15,478.98 Million in 2024, expanding at a CAGR of 7.98% from 2024 to 2032.

Patient Blood Management (PBM) is a comprehensive, evidence-based approach aimed at optimizing the care of patients who may require blood transfusions. It focuses on minimizing the need for transfusions by utilizing various strategies such as improving the patient's own blood volume and quality before, during, and after medical procedures. PBM includes three main pillars: optimization of erythropoiesis (promoting the body's natural production of red blood cells), minimization of blood loss (reducing surgical and diagnostic blood loss), and patient-centered transfusion strategies (ensuring transfusions are given only when absolutely necessary). The goal of PBM is to enhance patient outcomes by improving the management of anemia, reducing the risks associated with transfusions, and promoting the use of alternatives. This approach is particularly beneficial in surgical settings, trauma care, and chronic conditions where blood management plays a vital role in recovery and overall health.

Patient Blood Management Market- Market Dynamics

Rising Prevalence of Anemia and Chronic Diseases

The increasing prevalence of anemia and chronic diseases, such as cardiovascular disorders, cancer, and kidney disease, is a major driver for the growth of the Patient Blood Management (PBM) market. These conditions often lead to significant blood loss or decreased red blood cell production, necessitating more effective blood management strategies. As the global population ages and the incidence of these diseases rises, healthcare providers are turning to PBM to optimize blood use, reduce the need for transfusions, and improve patient outcomes. PBM strategies help manage anemia through tailored therapies and interventions, reducing the risks associated with transfusions and enhancing recovery. Consequently, the growing burden of chronic diseases is driving demand for PBM solutions that focus on minimizing blood loss, improving erythropoiesis, and offering alternatives to traditional transfusions. This trend significantly impacts the market's expansion.

PATIENT BLOOD MANAGEMENT Market- Key Insights

According to our research analyst, the global Patient Blood Management Market is expected to develop at a CAGR of approximately 7.98% between 2024-2032.

Segmented by Product in 2024, the Instruments category dominated the market.

Based on End User segmentation, the Hospitals generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Patient Blood Management Market- Segmentation Analysis:

The global Patient Blood Management market is divided into three categories: product, component, end user and region.

The Patient Blood Management (PBM) market is segmented into four key product categories: Instruments, Accessories, Reagents and Kits, and Software. Among these, Instruments are expected to dominate the market. This segment includes devices such as blood collection systems, blood processing equipment, and diagnostic instruments used to monitor and manage blood-related conditions. The dominance of instruments is attributed to their critical role in enabling accurate blood analysis, reducing blood loss, and enhancing transfusion practices in clinical settings. As PBM emphasizes minimizing blood loss and optimizing blood use, instruments are central to these objectives. Additionally, advancements in medical technologies and the growing adoption of blood-saving surgical techniques drive the demand for innovative, high-performance instruments. The importance of precise blood management in surgeries and critical care, coupled with increasing healthcare investments, positions instruments as the leading product category within the PBM market.

By End User the market is segmented into Blood Banks, Hospitals and Diagnostic Clinics and & Pathology Labs. Among these, the Hospitals segment is set to dominate. Hospitals are the primary healthcare settings where PBM practices are most extensively applied, particularly in surgical procedures, trauma care, and critical patient management. With the high volume of blood transfusions, surgeries, and patient admissions, hospitals require comprehensive PBM systems to manage blood loss, optimize blood use, and reduce transfusion-related risks. The growing adoption of PBM in hospitals is driven by the increasing number of complex surgeries, the rising incidence of chronic diseases, and the emphasis on improving patient outcomes. Additionally, hospitals are increasingly implementing advanced technologies for blood management, contributing to the expansion of PBM practices. While blood banks and diagnostic clinics also play essential roles in PBM, hospitals remain the dominant end user due to their direct involvement in patient care and treatment.

Patient Blood Management Market- Geographical Insights

Geographically, the Patient Blood Management Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Patient Blood Management (PBM) market, driven by the advanced healthcare infrastructure and the growing adoption of PBM practices in hospitals and healthcare facilities. The U.S. leads the market, where healthcare systems are increasingly focusing on reducing transfusion-related complications and optimizing patient outcomes through PBM solutions. Regulatory support from agencies like the FDA, along with rising awareness about the benefits of PBM, further fuels its adoption. Additionally, the presence of key market players and continuous technological advancements in blood management instruments contribute to North America's market leadership. The region's robust healthcare spending and an aging population requiring complex medical treatments further drive the demand for PBM solutions.

Europe is another key region in the PBM market, with significant growth attributed to a strong healthcare system, an aging population, and an increasing emphasis on minimizing blood loss and transfusions. Countries such as Germany, the U.K., and France lead the European market, with healthcare providers increasingly adopting PBM practices to enhance patient safety and reduce healthcare costs. The European Union's healthcare policies support the adoption of PBM strategies, particularly in hospitals and surgical centers. In addition, advancements in medical technology, such as blood-saving surgical instruments and diagnostic tools, play a pivotal role in driving market growth. Europe's progressive approach to healthcare and patient care ensures continued demand for PBM solutions in the region.

Patient Blood Management Market- Competitive Landscape:

The competitive dynamics of the Patient Blood Management (PBM) market are shaped by both established players and emerging innovators. Major companies like Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, and Immucor, Inc. lead the market, offering a range of advanced PBM solutions that prioritize safety, efficiency, and compliance with regulatory standards. These companies focus heavily on research and development to improve blood management systems and enhance transfusion protocols. New players are also entering the market with innovative technologies, such as advanced diagnostic tools and blood-saving surgical instruments. The competition among these companies encourages continuous product advancements and ensures a steady supply of high-quality PBM solutions. For instance, F. Hoffmann-La Roche Ltd. and Grifols, S.A. have been actively expanding their product portfolios, while B. Braun Melsungen AG and Bio-Rad Laboratories, Inc. continue to strengthen their positions through strategic acquisitions and collaborations.

Recent Developments:

In 2023, Grifols acquired 25 plasma donation centers in the U.S. from BPL Plasma Inc., enhancing its capacity by approximately 1 million liters annually. This strategic move strengthens Grifols' global leadership in plasma collection, supporting the growing demand for plasma-derived therapies. The acquisition aligns with Grifols' commitment to increasing patient access to life-saving treatments.

In October 2024, Terumo Blood and Cell Technologies introduced the Reveos(TM) Automated Blood Processing System in the U.S., in collaboration with Blood Centers of America. This innovative system automates the separation of whole blood into its components platelets, plasma, and red blood cells streamlining the process and improving efficiency. Reveos aims to enhance blood center operations and meet the increasing demand for blood products.

In August 2022, Abbott Laboratories launched a new blood testing platform designed to improve the accuracy and speed of diagnostics in patient blood management. This advanced platform supports healthcare providers in making timely and informed decisions, optimizing patient outcomes, and reducing the need for unnecessary transfusions. Abbott's innovation underscores its commitment to advancing PBM practices.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT BLOOD MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Haemonetics Corporation
  • Fresenius Se & Co. KGaA
  • Terumo Corporation
  • Immucor, Inc.
  • B. Braun Melsungen AG
  • Macopharma
  • Biomerieux SA
  • Kaneka Corporation
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Grifols, S.A.
  • F. Hoffmann-La Roche Ltd.
  • Others

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Blood Processing Devices
  • Centrifuges
  • Blood Cell Processors
  • Blood Transfusion Devices
  • Apheresis Machines
  • Plasma & Plasma Component Separators
  • Cell Salvage Systems
  • Other Transfusion Devices
  • Blood Culture Screening Devices
  • Automated Blood Culture Systems
  • Supporting Laboratory Equipment
  • Diagnostic & Testing Instruments
  • PCR Instruments
  • Hematology Analyzers
  • NGS Platforms
  • Blood Grouping Analyzers
  • Blood Storage Devices
  • Medical Refrigerators
  • Medical Freezers
  • Accessories
  • Syringes & Needles
  • Vials & Tubes
  • Blood Bags
  • Other Accessories
  • Reagents and Kits
  • Blood Culture Media
  • Blood Typing Reagents
  • Slide Staining Reagents
  • Assay Kits
  • Other Reagents
  • Software
  • Blood Bank Management Software
  • Transfusion Management Software
  • Other Software

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Whole Blood & Red Blood Cells
  • Plasma

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Blood Banks
  • Hospitals
  • Diagnostic Clinics and & Pathology Labs

GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Patient Blood Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Patient Blood Management Market Snippet by Product
    • 2.1.2. Patient Blood Management Market Snippet by Component
    • 2.1.3. Patient Blood Management Market Snippet by End User
    • 2.1.4. Patient Blood Management Market Snippet by Country
    • 2.1.5. Patient Blood Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Patient Blood Management Key Market Trends

  • 3.1. Patient Blood Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Patient Blood Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Patient Blood Management Market Opportunities
  • 3.4. Patient Blood Management Market Future Trends

4. Patient Blood Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Patient Blood Management Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Patient Blood Management Market Landscape

  • 6.1. Patient Blood Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Patient Blood Management Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Instruments
      • 7.1.2.1. Blood Processing Devices
      • 7.1.2.1.1. Centrifuges
      • 7.1.2.1.2. Blood Cell Processors
      • 7.1.2.2. Blood Transfusion Devices
      • 7.1.2.2.1. Apheresis Machines
      • 7.1.2.2.2. Plasma & Plasma Component Separators
      • 7.1.2.2.3. Cell Salvage Systems
      • 7.1.2.2.4. Other Transfusion Devices
      • 7.1.2.3. Blood Culture Screening Devices
      • 7.1.2.3.1. Automated Blood Culture Systems
      • 7.1.2.3.2. Supporting Laboratory Equipment
      • 7.1.2.4. Diagnostic & Testing Instruments
      • 7.1.2.4.1. PCR Instruments
      • 7.1.2.4.2. Hematology Analyzers
      • 7.1.2.4.3. NGS Platforms
      • 7.1.2.4.4. Blood Grouping Analyzers
      • 7.1.2.5. Blood Storage Devices
      • 7.1.2.5.1. Medical Refrigerators
      • 7.1.2.5.2. Medical Freezers
    • 7.1.3. Accessories
      • 7.1.3.1. Syringes & Needles
      • 7.1.3.2. Vials & Tubes
      • 7.1.3.3. Blood Bags
      • 7.1.3.4. Other Accessories
    • 7.1.4. Reagents and Kits
      • 7.1.4.1. Blood Culture Media
      • 7.1.4.2. Blood Typing Reagents
      • 7.1.4.3. Slide Staining Reagents
      • 7.1.4.4. Assay Kits
      • 7.1.4.5. Other Reagents
    • 7.1.5. Software
      • 7.1.5.1. Blood Bank Management Software
      • 7.1.5.2. Transfusion Management Software
      • 7.1.5.3. Other Software

8. Patient Blood Management Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 8.1.2. Whole Blood & Red Blood Cells
    • 8.1.3. Plasma

9. Patient Blood Management Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Blood Banks
    • 9.1.3. Hospitals
    • 9.1.4. Diagnostic Clinics and & Pathology Labs

10. Patient Blood Management Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Patient Blood Management Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Patient Blood Management Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Patient Blood Management Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Patient Blood Management Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Patient Blood Management Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Patient Blood Management Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Haemonetics Corporation
    • 11.2.2. Fresenius Se & Co. KGaA
    • 11.2.3. Terumo Corporation
    • 11.2.4. Immucor, Inc.
    • 11.2.5. B. Braun Melsungen AG
    • 11.2.6. Macopharma
    • 11.2.7. Biomerieux SA
    • 11.2.8. Kaneka Corporation
    • 11.2.9. Bio-Rad Laboratories, Inc.
    • 11.2.10. Abbott Laboratories
    • 11.2.11. Grifols, S.A.
    • 11.2.12. F. Hoffmann-La Roche Ltd.
    • 11.2.13. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us